Voriconazole has become the new standard of care in the treatment of invasive aspergillosis which may occur in immunocompromised patients, including allogeneic BMT, other hematologic cancers, and solid organ transplants.
Voriconazole has become the new standard of care in the treatment of invasive aspergillosis. This was including allogeneic BMT. This was including other hematologic cancers. This was including solid organ transplants. This treatment of invasive aspergillosis may occur in immunocompromised patients.